Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Synthetic Biology
Bio-Techne to acquire Namocell
Namocell's instrument portfolio includes Pala, a two-laser system with up to 11 fluorescent detection channels, and Hana, a single-laser system with two fluorescent detection channels.
June 21, 2022
Sherlock gets $5M to advance COVID-19 self-test platform
The Bill & Melinda Gates Foundation provided the grant for the instrument-free, synthetic biology-based molecular diagnostic platform that can be used at home and at room temperature. The platform can be adapted to work on a simple paper strip test or to provide an electrochemical readout that can be read with a mobile phone.
December 15, 2020
Agilent christens new R&D center in Singapore
The NUS-Agilent Hub for Translation & Capture aims to boost clinical diagnostics through biochemical innovation and research data analytics at laboratories based at the university and hospital. Scientists, clinicians, and industry partners will have 1,000 sq m of research space to collaborate and translate biochemical research into clinical applications.
August 19, 2019
Page 1 of 1